Predicting Optimal Dihydroartemisinin-Piperaquine Regimens to Prevent Malaria During Pregnancy for Human Immunodeficiency Virus–Infected Women Receiving Efavirenz

BACKGROUND: A monthly treatment course of dihydroartemisinin-piperaquine (DHA-PQ) effectively prevents malaria during pregnancy. However, a drug–drug interaction pharmacokinetic (PK) study found that pregnant human immunodeficiency virus (HIV)–infected women receiving efavirenz-based antiretroviral...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Infect Dis
Autori principali: Wallender, Erika, Vucicevic, Katarina, Jagannathan, Prasanna, Huang, Liusheng, Natureeba, Paul, Kakuru, Abel, Muhindo, Mary, Nakalembe, Mirium, Havlir, Diane, Kamya, Moses, Aweeka, Francesca, Dorsey, Grant, Rosenthal, Philip J, Savic, Radojka M
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2018
Soggetti:
Major Articles and Brief Reports
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5853566/
https://ncbi.nlm.nih.gov/pubmed/29272443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jix660
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi